Literature DB >> 25467638

Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.

Edward Ofori1, Ofer Pasternak2, Peggy J Planetta1, Roxana Burciu1, Amy Snyder1, Marcelo Febo3, Todd E Golde4, Michael S Okun5, David E Vaillancourt6.   

Abstract

Measures from diffusion magnetic resonance imaging reflect changes in the substantia nigra of Parkinson's disease. It is the case, however, that partial volume effects from free water can bias diffusion measurements. The bi-tensor diffusion model was introduced to quantify the contribution of free water and eliminates its bias on estimations of tissue microstructure. Here, we test the hypothesis that free water is elevated in the substantia nigra for Parkinson's disease compared with control subjects. This hypothesis was tested between large cohorts of Parkinson's disease and control participants in a single-site study and validated against a multisite study using multiple scanners. The fractional volume of free water was increased in the posterior region of the substantia nigra in Parkinson's disease compared with control subjects in both the single-site and multi-site studies. We did not observe changes in either cohort for free-water-corrected fractional anisotropy or free-water-corrected mean diffusivity. Our findings provide new evidence that the free-water index reflects alteration of the substantia nigra in Parkinson's disease, and this was evidenced across both single-site and multi-site cohorts.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diffusion MRI; Free-water mapping; Parkinson's disease; Substantia nigra

Mesh:

Year:  2014        PMID: 25467638      PMCID: PMC4315708          DOI: 10.1016/j.neurobiolaging.2014.10.029

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  48 in total

1.  Characterization and propagation of uncertainty in diffusion-weighted MR imaging.

Authors:  T E J Behrens; M W Woolrich; M Jenkinson; H Johansen-Berg; R G Nunes; S Clare; P M Matthews; J M Brady; S M Smith
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

2.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.

Authors:  Patrice Péran; Andrea Cherubini; Francesca Assogna; Fabrizio Piras; Carlo Quattrocchi; Antonella Peppe; Pierre Celsis; Olivier Rascol; Jean-François Démonet; Alessandro Stefani; Mariangela Pierantozzi; Francesco Ernesto Pontieri; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Brain       Date:  2010-08-23       Impact factor: 13.501

3.  Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.

Authors:  Guangwei Du; Mechelle M Lewis; Martin Styner; Michele L Shaffer; Suman Sen; Qing X Yang; Xuemei Huang
Journal:  Mov Disord       Date:  2011-05-26       Impact factor: 10.338

4.  Unbiased average age-appropriate atlases for pediatric studies.

Authors:  Vladimir Fonov; Alan C Evans; Kelly Botteron; C Robert Almli; Robert C McKinstry; D Louis Collins
Journal:  Neuroimage       Date:  2010-07-23       Impact factor: 6.556

5.  Differences in brain activation between tremor- and nontremor-dominant Parkinson disease.

Authors:  Janey Prodoehl; Peggy J Planetta; Ajay S Kurani; Cynthia L Comella; Daniel M Corcos; David E Vaillancourt
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

6.  Case control study of diffusion tensor imaging in Parkinson's disease.

Authors:  L-L Chan; H Rumpel; K Yap; E Lee; H-V Loo; G-L Ho; S Fook-Chong; Y Yuen; E-K Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-05       Impact factor: 10.154

7.  In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM.

Authors:  Yoko Shigemoto; Hiroshi Matsuda; Kouhei Kamiya; Norihide Maikusa; Yasuhiro Nakata; Kimiteru Ito; Miho Ota; Naofumi Matsunaga; Noriko Sato
Journal:  Neuroimage Clin       Date:  2013-04-05       Impact factor: 4.881

8.  CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment.

Authors:  Rok Berlot; Claudia Metzler-Baddeley; Derek K Jones; Michael J O'Sullivan
Journal:  Neuroimage       Date:  2014-02-03       Impact factor: 6.556

9.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.

Authors:  Stefan T Schwarz; Maryam Abaei; Vamsi Gontu; Paul S Morgan; Nin Bajaj; Dorothee P Auer
Journal:  Neuroimage Clin       Date:  2013-10-14       Impact factor: 4.881

View more
  62 in total

1.  Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.

Authors:  Edward Ofori; Florian Krismer; Roxana G Burciu; Ofer Pasternak; Johanna L McCracken; Mechelle M Lewis; Guangwei Du; Nikolaus R McFarland; Michael S Okun; Werner Poewe; Christoph Mueller; Elke R Gizewski; Michael Schocke; Christian Kremser; Hong Li; Xuemei Huang; Klaus Seppi; David E Vaillancourt
Journal:  Mov Disord       Date:  2017-07-17       Impact factor: 10.338

2.  Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6.

Authors:  Nyeonju Kang; Evangelos A Christou; Roxana G Burciu; Jae Woo Chung; Jesse C DeSimone; Edward Ofori; Tetsuo Ashizawa; Sankarasubramon H Subramony; David E Vaillancourt
Journal:  Brain Struct Funct       Date:  2016-06-28       Impact factor: 3.270

3.  Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease.

Authors:  Guangwei Du; Mechelle M Lewis; Christopher Sica; Lan Kong; Xuemei Huang
Journal:  Ann Neurol       Date:  2018-12-19       Impact factor: 10.422

4.  Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.

Authors:  Edward Ofori; Ofer Pasternak; Peggy J Planetta; Hong Li; Roxana G Burciu; Amy F Snyder; Song Lai; Michael S Okun; David E Vaillancourt
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

5.  Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism.

Authors:  Trina Mitchell; Derek B Archer; Winston T Chu; Stephen A Coombes; Song Lai; Bradley J Wilkes; Nikolaus R McFarland; Michael S Okun; Mieniecia L Black; Ellen Herschel; Tanya Simuni; Cynthia Comella; Tao Xie; Hong Li; Todd B Parrish; Ajay S Kurani; Daniel M Corcos; David E Vaillancourt
Journal:  Hum Brain Mapp       Date:  2019-08-12       Impact factor: 5.038

6.  Free-water and free-water corrected fractional anisotropy in primary and premotor corticospinal tracts in chronic stroke.

Authors:  Derek B Archer; Carolynn Patten; Stephen A Coombes
Journal:  Hum Brain Mapp       Date:  2017-06-07       Impact factor: 5.038

7.  Multimodal dopaminergic and free-water imaging in Parkinson's disease.

Authors:  Jing Yang; Derek B Archer; Roxana G Burciu; Martijn L T M Müller; Arnab Roy; Edward Ofori; Nicolaas I Bohnen; Roger L Albin; David E Vaillancourt
Journal:  Parkinsonism Relat Disord       Date:  2019-01-06       Impact factor: 4.891

8.  Parkinson's disease biomarkers program brain imaging repository.

Authors:  Edward Ofori; Guangwei Du; Debra Babcock; Xuemei Huang; David E Vaillancourt
Journal:  Neuroimage       Date:  2015-05-12       Impact factor: 6.556

9.  Re-examining age-related differences in white matter microstructure with free-water corrected diffusion tensor imaging.

Authors:  Jordan A Chad; Ofer Pasternak; David H Salat; J Jean Chen
Journal:  Neurobiol Aging       Date:  2018-08-01       Impact factor: 4.673

Review 10.  Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.

Authors:  Jing Yang; Roxana G Burciu; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.